Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MNK | Mallinckrodt Plc | 1.58% | 34.68 | 21.1% | $126.04m | |
| PRGO | Perrigo Co. Plc | 3.64% | 72.96 | 6.7% | $115.08m | |
| SHPG | Shire PLC Sponsored ADR | -0.63% | 170.42 | 0.4% | $114.29m | |
| ENDP | Endo International Plc | -1.94% | 15.64 | 8.9% | $89.03m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.40% | 173.81 | 2.2% | $72.23m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 0.20% | 103.42 | 18.7% | $68.63m | |
| SAGE | SAGE Therapeutics, Inc. | 2.03% | 152.08 | 9.6% | $57.16m | |
| UTHR | United Therapeutics Corporation | -2.97% | 125.61 | 14.4% | $50.56m | |
| CTLT | Catalent Inc | 0.39% | 40.94 | 2.6% | $47.83m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 1.59% | 136.06 | 6.8% | $43.22m | |
| PTLA | Portola Pharmaceuticals, Inc. | 0.04% | 25.59 | 7.7% | $40.54m | |
| SUPN | Supernus Pharmaceuticals, Inc. | 2.99% | 44.80 | 6.2% | $40.22m | |
| ICLR | ICON Plc | 0.23% | 143.68 | 4.2% | $39.99m | |
| ZGNX | Zogenix, Inc. | 1.15% | 48.60 | 11.9% | $37.44m | |
| HZNP | Horizon Pharma plc | -0.15% | 20.57 | 7.5% | $32.74m |
Company Profile
Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.